Division of Translational Cancer Research
Organisational unit: Division
Research areas and keywords
UKÄ subject classification
- Cancer and Oncology
- Cell and Molecular Biology
The Division of Translational Cancer Research (TCR) was founded 2013 in conjunction with the formation of Lund University Cancer Center (LUCC) at Medicon Village. TCR consists of nine research groups with different areas of expertise, but together working on projects with the common goal of improving cancer diagnostics and cancer therapy. Our multidisciplinary experimental settings include human genetics, mouse genetics, human tissue platform, stem cell biology and advanced maging, aiming at creating novel diagnostic tools and therapeutic modalities. We believe that the impact of ongoing projects at TCR will open up new horizons and opportunities for individualized treatment of cancer patients, which includes diagnostic tests for matching the right drug to the right patient.
Recent research outputs
Emma U Hammarlund, Axelrod, R., Amend, S. R. & Brown, J. S., 2020 May 12, In : Molecular cancer research : MCR.
Research output: Contribution to journal › Review article
Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progressionCharlotte Levin Tykjær Jørgensen, Carina Forsare, Pär Ola Bendahl, Falck, A. K., Mårten Fernö, Lövgren, K., Kristina Aaltonen & Lisa Rydén, 2020 Apr 16, In : Breast Cancer Research and Treatment. 181, 2, p. 369-381 13 p.
Research output: Contribution to journal › Article
View All (339)